Healthcare Services

Diverticulitis Market Growth Linked to Smoking Prevalence

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Diverticulitis Disease Market Expected To Change From 2026 To 2030?

The diverticulitis disease market has experienced substantial expansion in recent years. It is anticipated to grow from $2.02 billion in 2025 to $2.21 billion in 2026, at a compound annual growth rate (CAGR) of 9.0%. The growth observed in the past can be ascribed to an expanding aging population, dietary patterns low in fiber, inadequate early diagnosis, treatment models centered in hospitals, and an increasing occurrence of gastrointestinal disorders.

The diverticulitis disease market is projected to experience robust expansion in the coming years, reaching $3.22 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.9%. This anticipated growth during the forecast period is primarily due to increased awareness of preventive digestive health, enhanced access to imaging, the expansion of outpatient care services, a decrease in surgical intervention rates, and a greater emphasis on lifestyle modifications. Key trends anticipated for this period involve a rise in the diagnosis of uncomplicated diverticulitis cases, an increasing preference for conservative and outpatient management strategies, a growing adoption of imaging-based diagnostic methods, the broadening of antibiotic and supportive care treatments, and heightened awareness regarding dietary and lifestyle management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report

What Key Factors Are Affecting The Diverticulitis Disease Market Demand?

The increasing incidence of smoking dependence is projected to fuel the expansion of the diverticulitis disease market in the future. This addiction describes a strong reliance on products containing nicotine, including cigarettes, vaping devices, and other tobacco products. The rise in smoking addiction is attributed to aggressive promotional efforts, increased social acceptance, stressors, and the wider availability of electronic cigarettes and vaping devices. This trend is further supported by diverticulitis treatment, as smoking impairs blood flow to the colon, heightening the likelihood and intensity of diverticular disease, consequently boosting the demand for diagnostic and treatment solutions. For example, an October 2024 study by the European Respiratory Society (ERS), a non-profit organization based in Switzerland, on smoking trends among younger populations, demonstrated a notable increase in smoking prevalence, with 22.5% of individuals reporting smoking in 2022, rising to 40.1% in 2024. Consequently, the growing prevalence of smoking addiction will stimulate the expansion of the diverticulitis disease market.

How Is Segmentation Applied In The Diverticulitis Disease Market Segment Analysis?

The diverticulitis disease market covered in this report is segmented –

1) By Type: Uncomplicated, Complicated

2) By Diagnosis: Computed Tomography (Ct) Scan, Ultrasound, Urine Test, Blood Test

3) By Treatment: Medications, Surgery, Supportive Care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (Iv) Fluids

4) By End-User: Specialty Centers, Hospitals, Research Centers

Subsegments:

1) By Uncomplicated: Outpatient Treatment, Dietary Management, Antibiotic Therapy

2) By Complicated: Hospitalization, Surgical Intervention, Intravenous Antibiotics, Abscess Drainage

What Trends Are Influencing Changes In The Diverticulitis Disease Market?

Leading companies in the diverticulitis disease market are developing and seeking approval for innovative drugs to maintain their competitive standing. Pharmaceutical development can result in more effective treatments for diverticulitis, thereby lowering the risk of complications and enhancing patient outcomes. For example, in April 2023, the United States Food and Drug Administration, a US-based federal organization, granted approval for Seres’ microbiota drug intended for recurrent gut infections. This medication is designed to treat repeated gut infections and prevent the re-occurrence of Clostridioides difficile (C. diff.) infections in adults aged 18 and over. The approval of Vowst stemmed from a clinical trial that included 346 patients experiencing recurrent CDI. The study revealed that patients treated with Vowst were significantly less prone to a recurrence of the infection than those who received a placebo. The drug is administered orally and utilizes microbiota containing Firmicutes spores, which are known to contribute to a robust microbiome capable of resisting C. diff. colonization.

Who Are The Companies Participating In The Diverticulitis Disease Market Environment?

Major companies operating in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.

Get The Full Diverticulitis Disease Market Report:

https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report

Which Region Has The Greatest Market Share In The Diverticulitis Disease Market?

North America was the largest region in the diverticulitis disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diverticulitis disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Diverticulitis Disease Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report

Browse Through More Reports Similar to the Global Diverticulitis Disease Market 2026, By The Business Research Company

Ulcerative Colitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/ulcerative-colitis-global-market-report

Intestinal Pseudo Obstruction Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/intestinal-pseudo-obstruction-treatment-global-market-report

Intestinal Pseudo Obstruction Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/intestinal-pseudo-obstruction-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795